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The de novo design of a 
biocompatible and functional 
integral membrane protein using 
minimal sequence complexity
Christophe J. Lalaurie1, Virginie Dufour1,3, Anna Meletiou1, Sarah Ratcliffe1, Abigail Harland1, 
Olivia Wilson1, Chiratchaya Vamasiri1, Deborah K. Shoemark1,3, Christopher Williams2,3, 
Christopher J. Arthur2, Richard B. Sessions1,3, Matthew P. Crump  2,3, J. L. Ross Anderson1,3 & 
Paul Curnow1,3
The de novo design of integral membrane proteins remains a major challenge in protein chemistry. Here, 
we describe the bottom-up design of a genetically-encoded synthetic membrane protein comprising 
only four amino acids (L, S, G and W) in the transmembrane domains. This artificial sequence, which 
we call REAMP for recombinantly expressed artificial membrane protein, is a single chain of 133 
residues arranged into four antiparallel membrane-spanning α-helices. REAMP was overexpressed 
in Escherichia coli and localized to the cytoplasmic membrane with the intended transmembrane 
topology. Recombinant REAMP could be extracted from the cell membrane in detergent micelles 
and was robust and stable in vitro, containing helical secondary structure consistent with the original 
design. Engineered mono- and bis-histidine residues in the membrane domain of REAMP were able to 
coordinate heme in vitro, in a manner reminiscent of natural b-type cytochromes. This binding shifted 
the electrochemical potential of the cofactor, producing a synthetic hemoprotein capable of nascent 
redox catalysis. These results show that a highly reduced set of amino acids is sufficient to mimic some 
key properties of natural proteins, and that cellular biosynthesis is a viable route for the production of 
minimal de novo membrane sequences.
Integral membrane proteins play vital roles in biological systems including solute transport, signal transduction, 
and energy generation. Despite recent progress in structural biology, for many such proteins the relationships 
between sequence, structure and function remain unclear. One powerful means of understanding these relation-
ships at a fundamental level is to design membrane proteins from first principles (de novo).
Previous studies have described chemically-synthesised de novo sequences that oligomerize to become chan-
nels, transporters, and electron transfer proteins in synthetic membranes1–4. An alternative and less well-explored 
strategy is to biosynthesise genetically-encoded de novo membrane proteins using the natural cellular machinery. 
Cellular expression is of interest since it provides access to long and hydrophobic amino acid sequences that are 
not chemically accessible, enables directed evolution and library screening in cell cultures, and could allow the 
expressed protein to influence the membrane biology of a living cell. The potential of cell expression has now been 
clearly demonstrated by a series of biocompatible synthetic membrane proteins obtained from the redesign of a 
soluble de novo sequence5.
Using expressible de novo proteins to explore multiple facets of membrane protein biology such as biosynthe-
sis, targeting, topology control, folding, assembly, and cofactor binding is also an attractive proposition. The most 
powerful insights are likely to come from simple minimalist sequences that offer a neutral design background. 
This is borne out by the extensive use of model transmembrane helices with limited sequence diversity to inves-
tigate membrane insertion6–10, topology11–13, folding14–18 and assembly19–21. A logical extension of this approach 
is to develop new minimal systems that are geared towards a deeper understanding of oligomeric and multipass 
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transmembrane proteins. It has already been shown that bottom-up designs with very low sequence complex-
ity can be tolerated by the cell11,22,23, but it is not yet clear whether these simplistic proteins can bridge the gap 
between being both resident in cellular membranes and compatible with the in vitro biophysical methods nec-
essary for protein characterization. A reasonable design target for such a protein would be a tetrahelical bundle, 
which is a common motif in natural membrane proteins and can support various functions2–4.
Here, we present a new minimal de novo protein that can be successfully expressed into the cytoplasmic mem-
brane of E. coli and subsequently purified for further study. This sequence, named REAMP to denote a recom-
binantly expressed artificial membrane protein, uses only Leu, Ser, Gly and Trp to define four transmembrane 
helices. The expression and cellular localization of REAMP were investigated and conditions were identified that 
could support REAMP purification and characterization in vitro. This sequence was then rationally engineered 
for cofactor binding, producing a synthetic metalloprotein with measurable catalytic activity. Our findings estab-
lish REAMP as a novel biocompatible scaffold that can imitate some features of natural membrane proteins.
Results
Protein design. To guide and constrain the design process we turned to the SMR family of small mem-
brane proteins. Because our intention was to design a four-helix bundle, members of this family were of interest 
since the SMR protomer contains four contiguous and hydrophobic TM helices connected by short extramem-
brane loops. We identified eight particular SMR proteins (accession numbers P23895, Q2FD83, P69937, P14319, 
P69926, B0R6K7, P69210, P69213) which are among those to have been characterised and so are validated as 
authentic gene products. We reasoned that this deliberately restricted dataset, featuring diverse and functionally 
distinct proteins from E. coli, A. baumanii, S. oneidensis, S. aureus, M tuberculosis, and H. salinarum, would be 
sufficient to capture the general character of the natural amino acid sequences while avoiding bias towards any 
specific conserved residues or motifs24. We did not wish to recreate any specific secondary, tertiary or quaternary 
structure of the SMRs, nor to emulate the observed hydrophobic burial of functionally-important charged resi-
dues, but only to generate a basic template for our design.
Following a multiple sequence alignment, the consensus sequence of each transmembrane domain of the 
SMRs could be abstracted to the general pattern hhhhpGhGhhhhphhGhhhhp, where h = hydrophobic and 
p = polar (Supplementary Table 1 and Fig. 1, box). The length of this segment (21 residues) should be sufficient 
to span the hydrophobic core of a natural lipid bilayer. To translate this general pattern into an idealized de novo 
sequence, leucine (L) was introduced at every h position and serine (S) at every p position. We used these particu-
lar residues since L is the predominant amino acid in natural transmembrane proteins25 and is multifunctional, 
being able to engage in in protein-protein and protein-lipid interactions. S was selected as a small polar residue 
that is known to contribute to helix packing in membrane proteins26. Glycine (G) was retained at positions where 
it was relatively conserved in the consensus, given the particular role that it can play in promoting helix-helix 
interactions in the membrane26–28. Specific patterns and motifs known to occur in natural membrane proteins 
were otherwise deliberately avoided to minimize sequence complexity. Four helices each comprising the ideal-
ized minimal sequence LLLLSGLGLLLLSLLGLLLLS were linked by three flexible loops of sequence SSGXXGSS, 
where X was glutamate in loops one and three and lysine in loop two. This was to constrain the transmembrane 
topology of REAMP according to the ‘positive inside’ rule11,29. A single tryptophan (W) was introduced at residue 
50, near the end of the second TM segment, to provide an optical signal, and for immunodetection a V5 antibody 
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Figure 1. Amino acid sequence, predicted topology, and computational model of the de novo membrane 
protein REAMP. The boxed region illustrates how a consensus sequence from a small set of natural proteins was 
translated into an idealized sequence for each transmembrane helix.
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epitope was introduced at the C-terminus. Two different tags to allow purification by affinity chromatography 
were then introduced (see below). The sequences of all constructs are given in Supplementary Fig. S1.
Bioinformatic analysis predicted with reasonable confidence that REAMP would form four transmembrane 
α-helices and conform to the designed topology with Nin/Cin orientation (Supplementary Table 2). Molecular 
dynamics simulations were used to further assess how REAMP would be accommodated within a generic lipid 
bilayer. In these simulations, REAMP rapidly approached a lower-energy structure relative to the starting confor-
mation characterized by modest helical tilting and distortion that is most pronounced in helices 2 and 3 (Fig. 1). 
A video of this trajectory is included as Supporting Information. The transmembrane domains of REAMP are 
mildly amphipathic because of the serine residues (Fig. S2). During simulations the slightly polar faces of the 
helices remained facing the interior of the bundle, sequestered from the hydrophobic lipid phase.
Protein expression and purification. REAMP was synthesized as a synthetic gene and cloned into a 
recombinant vector for expression in E. coli. Western blotting against the V5 epitope was used to confirm this 
expression and to show that the expressed REAMP was localized to the cell membrane (Fig. 2a). We additionally 
confirmed the membrane localization with a REAMP-GFP fusion protein (Fig. S3). Cell membranes were isolated 
by centrifugation and REAMP was extracted as a protein-detergent-lipid complex. This allowed the purification 
of REAMP in a single step by affinity chromatography using either His10 tag or triple Strep-tagII affinity tags at the 
C-terminus. The results obtained with either of these two tags were indistinguishable.
Figure 2. Affinity purification and characterization of REAMP. (a) Representative SDS-PAGE gel showing cell 
fractionation and purification of REAMP in Cymal-5. Immunodetection with anti-V5 (IB α-V5) confirms the 
protein identity and the success of the purification strategy. The uncropped blot is shown as Fig. S7. (b) Size 
exclusion chromatography shows that purified REAMP is homogenous and monodisperse in Cymal-5 with an 
apparent molecular weight of 65 kDa. SDS-PAGE analysis confirms that the peak is REAMP. The uncropped gel 
is presented as Fig. S8. (c) Purification of REAMP in other maltosides suggests that the protein contribution to 
the PDC is 43 ± 9 kDa, consistent with three protomers per micelle. Data are from SEC profiles shown in Fig. S9. 
(d) The PDC is apparently 60 kDa on blue native PAGE.
www.nature.com/scientificreports/
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A screen of the mild nonionic maltoside detergents showed that NM, DM, DDM and Cymal-5 could all 
support the purification of REAMP with yields of ~2 mg of purified protein per g total membrane protein. This 
is similar to yields obtained from the recombinant expression of natural membrane proteins. Interestingly, the 
REAMP-GFP fusion was produced at markedly higher levels of ~20 mg per g. REAMP was resolved as a single 
major species on SDS-PAGE, migrating close to the calculated theoretical weights of the His-tagged and triple 
StrepII-tagged constructs of 13.8 kDa and 17.8 kDa, respectively (Figs 2a, S4). In some instances purified REAMP 
ran as a doublet, suggesting multiple SDS binding isoforms (Figs 2a, S4). The identity of the purified protein was 
additionally confirmed by amino acid analysis and mass spectrometry (Figs S5, S6).
Detergent compatibility and oligomeric state. We next assessed the oligomeric state, aggregation 
propensity and dispersity of purified REAMP with size-exclusion chromatography (SEC). REAMP was homog-
enous and monodisperse in DM and Cymal-5, but the elution profiles in DDM and NM were more heteroge-
nous (Figs 2b; S9). Changes in the aggregation propensity in different detergent environments - even when those 
detergents are closely related - is a common characteristic of many membrane proteins. The elution volume of 
REAMP in Cymal-5 corresponded to a Stokes radius (Rs) of 3.5 nm. This translates to an apparent molecular mass 
of 65 kDa versus protein standards. A lipid assay determined that no host cell lipid was co-purified with REAMP, 
and so this apparent mass represents the protein-detergent complex (PDC). This was unexpected given that the 
monomer mass of His10-tagged REAMP is 13.8 kDa, and that the Cymal-5 micelle would be expected to contrib-
ute only 20–25 kDa to the complex. We judged that a PDC mass of 65 could represent three REAMP protomers 
per micelle.
We further interrogated this apparent oligomerization of REAMP in detergent micelles. Blue-native PAGE 
agreed with SEC, showing a single band at 60 kDa (Fig. 2d). Particle sizing with solution dynamic light scatter-
ing gave the same Rs of 3.6 ± 0.2 nm (compared with 3.0 ± 0.1 nm for the empty micelle). Following Erickson30 
we used gradient centrifugation to determine a sedimentation coefficient in Cymal-5 of 4.2 S relative to soluble 
protein standards (Fig. S10). Combining this with the Stokes radius according to Eq. 1 gave a molecular mass of 
60 kDa for the PDC. A REAMP-GFP fusion protein also eluted from size exclusion at an apparent mass consistent 
with three protomers per micelle (Fig. S3). Within the maltoside series tested, the apparent mass of the lowest 
mass peak was linear with micelle size (Fig. 2c) and we applied the method described by Kunji31 to determine by 
extrapolation that the contribution of REAMP to the micelle was 43 ± 9 kDa. Finally, nanoelectrospray MS32 only 
gave a peak for the REAMP monomer even at low voltages, confirming that the apparent homotrimer readily 
dissociated and so was not inherently stable nor an unrecoverable aggregate (Fig. S6). Analytical ultracentrifuga-
tion was not possible because REAMP was not stable in C8E5. Collectively, these findings suggest that REAMP 
is adventitiously purified at three protomers per micelle, but that this does not represent a specific aggregation 
complex.
Structure and topology. The structure and transmembrane topology of REAMP were characterized by 
circular dichroism (CD), NMR, and cysteine scanning mutagenesis. UV-CD showed that REAMP was clearly 
α-helical in all of the detergents tested, with strong negative deflections at 208 nm and 222 nm (Figs 3a, S11). Data 
recorded in DM and Cymal-5 were indistinguishable, and both the shape and intensity of the spectra suggested 
~60% helix overall. Helicity was slightly reduced in DDM and markedly reduced in NM. CD was also used to 
probe the thermal stability of REAMP (Fig. 3b). The CD signal showed a linear decrease to ~80% of the starting 
signal at 95 °C, typical for both natural membrane proteins and other de novo membrane sequences because of the 
high energetic cost of unfolding an alpha-helix in a hydrophobic environment4.
The 1H-15N HSQC NMR spectrum of REAMP generally showed poor chemical shift dispersion and reso-
lution, although a few well-dispersed peaks could be observed (such as the Trp indole proton at 10.1 ppm in 
the 1H dimension). This result most likely reflects a combination of the slow tumbling of the large PDC and the 
highly repetitive amino acid sequence, and may also indicate that the protein behaves as a dynamic molten glob-
ule. Although this requires further investigation beyond the scope of the current work, many de novo proteins 
are conformationally heterogeneous33–36 and this would be unsurprising since the REAMP design strategy did 
not dictate specific tertiary interactions. Engineering specific packing interactions into the minimal REAMP 
sequence should allow for improved structural definition in future design iterations.
Cysteine accessibility experiments were used to probe the transmembrane topology of REAMP. Single Cys res-
idues were introduced into the extramembrane loops to replace E26, S52, and E83. These experiments were car-
ried out in a S35H/L94H/L22A/L75A mutant background (see below) because this variant gave a much stronger 
western blot signal than the original parent sequence but otherwise behaved identically. When cysteines were 
placed in the periplasmic loops at E23C or E83C an intense band was observed in western blots of crude cell lysate 
and cell membrane fractions that presumably corresponded to a REAMP dimer (Fig. 4). This band accounted for 
approximately 50% and 95% of the total protein for E26C and E83C respectively. The presumed dimer band was 
abolished by the reducing reagent β-mercaptoethanol (β-ME), suggesting that it arises from inter-protein disul-
phide bonds formed in the oxidizing environment of the periplasm. In contrast, introducing a cysteine into the 
intracellular loop (S52C) showed no such dimer band, consistent with this linker being sequestered in the reduc-
ing environment of the cytoplasm. It thus appears that the topology of REAMP conforms to design, whereby the 
first and third loops are periplasmic and the second loop is intracellular.
Cofactor binding. Many natural proteins exploit a cofactor to achieve their biological function. One of the 
most prominent cofactors in membrane biochemistry is heme, which is responsible for electron transfer dur-
ing photosynthesis and oxidative phosphorylation. In terms of de novo design, engineering heme binding is of 
interest because of the functional diversity of heme metalloenzymes and because a well-defined binding site and 
tertiary structure are not necessarily required; indeed, heme binding can drive the ordering of de novo molten 
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globules34. Designed and re-designed sequences that bind to heme and related porphyrins have thus previously 
been studied in micelles and model lipid membranes2,4,37–40. The most common axial ligand for heme binding in 
both natural proteins and artificial proteins is histidine in either a mono-His or bis-His configuration41–43.
The computational model of REAMP (Fig. 1) was used to identify amino acids facing the protein interior 
that were candidates for mutation to His. This selection was refined by applying the design criteria that the res-
idue should be buried into the membrane by ~10 Å to allow partitioning of the bulk of the porphyrin ring. For 
bis-His coordination, two residues were selected that were diametrically opposed across the 4-helix bundle. To 
help relieve steric clashes between the porphyrin ring and inward-facing leucine residues a crude binding site was 
‘hollowed out’ by replacing L22 and L75 with alanine.
This process resulted in one mono-His and two bis-His variants of REAMP in a L22A/L75A background: 
REAMPS35H, REAMPS35H/S90H and REAMPS35H/L94H, where S35 is on helix 2 and S90 and L94 are on helix 4. Each 
of these variants was purified as an apoprotein in Cymal-5 as described above for REAMP (Fig. S12). Purification 
yields were similar to the REAMP parent or even slightly better in the case of REAMPS35H/L94H, which also gave a 
stronger signal on western blots. We thus used REAMPS35H/L94H as our bis-His construct.
Heme binding to these variants was assessed by UV/Vis absorbance spectroscopy (Fig. 5). A bulk detergent 
concentration of 0.1x CMC was sufficient to keep the protein stable while eliminating the background signal that 
arises from heme partitioning into empty micelles. Under these low-detergent conditions, introducing heme (as 
hemin) to REAMP gave data similar to a buffer-only control, showing a broad absorbance band with a modest 
peak at 394 nm (Fig. 5b). These samples remained brownish-green to the eye indicating that the heme remained 
in a relatively aqueous environment (Fig. 5a, left). In contrast, adding heme to REAMPS35H/L94H produced a visible 
red colour (Fig. 5a, right) and gave spectra consistent with hydrophobic burial and bis-His heme coordination 
(Fig. 5b). The Soret (B) band was red-shifted to 415 nm and other spectral features emerged in the Q-region 
between 500–700 nm (Fig. 5b). When these samples were reduced either electrochemically or with sodium dith-
ionite the Soret peak was shifted to 427 nm and the Q-bands were substantially sharpened (Figs S13, S15). There 
were subtle but observable differences between the heme spectra of mono-His and bis-His mutants (Fig. S13). 
The absorbance of the mono-His spectrum was less intense, with a shoulder toward shorter wavelengths. We were 
unable to study the effects of heme binding by protein NMR because of significant visible aggregation when the 
apoproteins were concentrated in dilute detergents.
Figure 3. Secondary and tertiary structure of REAMP. (a) Circular Dichroism shows that DM and Cymal-5 
support the highest degree of secondary structure. (b) Melting curves at 222 nm. (c) 1H-15N TROSY-HSQC 
spectrum of REAMP in Cymal-5 at 40 °C.
www.nature.com/scientificreports/
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All histidine variants showed tight binding of heme once the nonspecific background signal from the REAMP 
control had been subtracted. The binding stoichiometry was as expected based on design, being 1:1 heme:His and 
0.5:1 heme:His for mono-His and bis-His coordination, respectively (Fig. 5c). The apparent equilibrium dissocia-
tion constants (Kd) were 2.9 ± 0.2 μM for REAMPS35H and 2.2 ± 0.1 μM for REAMPS35H/L94H. The equivalent value 
for REAMP, albeit with a much smaller signal, was 5.6 ± 0.9 μM. Kinetic analysis showed that cofactor binding 
to the bis-His variant is rapid and is characterized by having both a faster on-rate and a slower off-rate than the 
REAMP control (Fig. S14). Values for Kd derived from kinetic data (koff /kon) were similar to those from equilib-
rium measurements, being 1.7 ± 0.4 μM for REAMPS35H/L94H and 4.5 ± 0.4 μM for REAMP.
Redox potentiometry was used to measure the midpoint equilibrium potential (Em) of both REAMPS35H/L94H 
and REAMP in the presence of heme (Figs 5d, S15). For REAMP, Em was −133 ± 3 mV vs standard hydrogen 
electrode. This is very close to previous values obtained for heme partitioned into detergent micelles38, where the 
reduction potential is increased over aqueous solvents because of the energetic cost of burying ferric heme within 
the hydrophobic micelle interior. For REAMPS35H/L94H the Em was shifted by +32 mV to −101 ± 5 mV. The most 
likely cause of this shift is coordination by at least one histidine and increased desolvation.
Peroxidase activity. A number of previous studies have shown that de novo metalloproteins can take part 
in electron transfer reactions34,44–46. The REAMPS35H/L94H hemoprotein was used in a classical peroxidase assay 
in which the reduction of H2O2 was coupled to the oxidation of ABTS. The results of this assay suggested that 
the REAMPS35H/L94H hemoprotein was indeed active in electron transfer, albeit to a very limited degree (Fig. 6). 
Figure 4. Transmembrane topology of REAMP. Introducing Cys residues in the periplasmic loops 
(E26C, E83C) results in apparent covalent dimer bands (D) that are abolished by the reducing reagent 
β-mercaptoethanol (β-ME). Top panel, representative western blot; bottom panel, percent dimer per lane 
(mean ± s.d., n = 3).
www.nature.com/scientificreports/
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The REAMPS35H/L94H hemoprotein slowly evolved a modest but distinguishable signal above control samples that 
corresponded to about 7 reactions per hemoprotein. This suggested that the catalytic activity was likely to be 
accompanied by rapid poisoning of the hemoprotein.
Discussion
The engineering and design of α-helical and β-barrel membrane proteins is now receiving increased attention47,48 
but remains an important problem that is relevant to both basic and applied science. One potential barrier to 
progress is that membrane proteins are notoriously difficult to produce recombinantly, because sequences that are 
so strongly biased towards hydrophobic amino acids are liable to aggregate. However, the results presented here 
show that the minimal de novo sequence REAMP is expressible, can be successfully processed by the cell, and is 
stable after purification. The implications of this are discussed below.
Although it is well-attested that fusion proteins can support the expression of synthetic transmembrane 
segments, it is less clear that this extends to standalone de novo sequences and examples are relatively scarce. 
The available evidence is that redesigned and de novo proteins comprised of a limited selection of hydropho-
bic amino acids (mainly L, I and A) can generally be expressed by the cell11,22,23,40 and localized to the plasma 
membrane11,22,23. Goparaju and colleagues40 used a fusion protein strategy to deliberately express a minimal de 
novo protein into inclusion bodies, so the intrinsic localization of that sequence is unknown. It thus appears that 
austere de novo membrane sequences of low complexity are broadly compatible with cellular expression. In the 
case of REAMP, this sequence appears to be rather malleable and can be mutated with little impact on protein 
expression; indeed some mutants are produced at higher yield than the parent construct. It will be interesting to 
interrogate random and rational sequence libraries of REAMP to determine which amino acid substitutions, in 
which positions, can be tolerated by the cell. Understanding the design parameters for the successful biogenesis 
Figure 5. Heme coordination. (a) Adding heme to a bis-Histidine variant of REAMP causes a colour change 
from green to red indicative of cofactor binding. (b) Representative UV/Vis spectroscopy showing spectral 
changes characteristic of heme binding to REAMPS35H/L94H. (c) Both mono-His and bis-His variants exhibited 
tight binding. Data are mean ± s.d, n = 3. (d) Bis-His coordination shifts the heme redox potential. Values are 
from fitting the reductive sweep (closed symbols) to the Nernst equation for a single electron reduction.
www.nature.com/scientificreports/
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of REAMP could help to identify generic principles that underpin the recombinant production of integral mem-
brane proteins. Any such insight might support the rational engineering of natural proteins to improve expression 
yields.
The results here also show that REAMP could be readily purified and characterised in the maltoside family of 
detergents (Figs 3, 5 and 6). Why was this protein so robust in vitro? Presumably the simplicity and small size of 
REAMP mean that there are few hydrophobic regions exposed from the detergent micelle. Additionally, REAMP 
is not evolved to suit a particular membrane environment or to make stabilizing interactions that cannot be 
satisfactorily mimicked by a detergent. REAMP purifies in an aggregation state of three proteins per micelle for 
unknown reasons, and it should be possible to engineer this oligomerization by changing the protein sequence. 
REAMP may thus represent a simple model for understanding the specific and non-specific association of mem-
brane proteins.
The design strategy for this first iteration of REAMP was deliberately simplistic and only tried to define the 
topology of secondary structure elements. NMR analysis of REAMP is consistent with a dynamic molten globule 
(Fig. 3), although this remains to be confirmed. Several investigators have found that molten globule states are 
good starting points for protein design33,36,49. The structural definition of REAMP could likely be improved by 
introducing specific packing motifs and other general features found in natural membrane proteins26–28. Similar 
strategies could also be employed to optimise and manipulate cofactor binding with the ultimate goal of assem-
bling a catalytic hemoprotein in vivo. Such a sequence could be the basis for a synthetic bioenergetic protein 
capable of biological electron transfer, or of acting as a novel enzyme at the cell membrane.
The prevalence and importance of metalloenzymes in biology has led to extensive efforts to incorporate metal 
cofactors into artificial proteins46,50,51. Of closest relevance here are those studies that have focused upon helical 
membrane domains. For example, the transmembrane region of the natural membrane protein Glycophorin A 
was subtly redesigned to generate synthetic peptide dimers that bind heme in micelles via bis-His coordination. 
The apparent Kd for heme binding was 0.5 μM, slightly lower than the 2.2 μM reported here for REAMP deriv-
atives38. The redox potential of this hemoprotein was −128 mV, so it does not show the same shift to higher 
voltages that we observe for REAMPS35H/L94H. More recently, the antimicrobial peptide VK22 was the inspiration 
for a membrane peptide dimer called HETPRO that exploited histidine ligation to bind two hemes with Kdapp of 
2.9 μM37. Both the redesigned Glycophorin A and HETPRO were also active in peroxidase assays, analogous to 
the activity shown here for the REAMP hemoprotein37,38. As well as peptide dimers, four-helix bundles have also 
been designed that can incorporate multiple copies of both natural and artificial porphyrins. In one example, 
the lipophilic peptide PRIME spontaneously assembles into a tetramer in detergent micelles and tightly binds 
the non-natural iron diphenylporphyrin at each of two distinct bis-His sites2. Goparaju and colleagues also used 
histidine to coordinate different porphyrins at individual sites within a tetrahelical peptide bundle, and extended 
this to include a highly minimal sequence that can be recovered from cellular inclusion bodies40. This latter hemo-
protein showed a substantial positive shift in redox potential, probably +100 mV above that seen here for REAMP 
derivatives, and it was possible to achieve light-activated electron transfer between the bound cofactors40. This 
work drew at least partly upon the prior design of amphiphilic de novo proteins, in which a hydrophobic section 
can be appended to a hydrophilic domain, and which can be engineered to include a porphyrin binding region 
directly inspired by the sequences of natural b-type cytochromes4. These constructs use histidine ligation to coor-
dinate a variety of different porphyrins in the lipophilic segment, and heme binding in particular can be very 
tight with Kd being 50 nM in the most favourable cases4. Collectively, these examples suggest that there is scope 
to improve the heme binding affinity of REAMP, and to explore whether REAMP derivatives can bind to other 
metalloporphyrins. Additionally, it should be possible to rationally modulate the redox potential of the REAMP 
hemoprotein and to engage multiple cofactors with a single protomer for intra- and interprotein electron transfer.
We thus show here that a deliberately naïve, minimal artificial sequence is successfully recognized by the cell 
machinery and can broadly imitate aspects of natural membrane proteins in vivo and in vitro. Future iterations of 
REAMP should be useful in probing the fundamental mechanisms of membrane protein biogenesis and assembly, 
and for developing functional de novo membrane proteins that interact with the cell. Overall, our results provide 
further evidence for the general feasibility of membrane protein design.
Figure 6. Redox catalysis by the REAMPS35H/L94H hemoprotein. (a) Photograph showing ABTS oxidation to a 
dark green product under the conditions used. (b,c) Representative absorbance scans showing the increased 
activity of the hemoprotein versus REAMP. (d) The evolution of oxidized ABTS by the REAMPS35H/L94H 
hemoprotein can be distinguished from background controls. These controls are REAMP + Heme (REAMP), 
heme only in the absence of any protein (-Protein), REAMPS35H/L94H apoprotein (-Hemin) and REAMPS35H/L94H 
hemoprotein with peroxide omitted (-H2O2). Data are mean ± s.d., n = 3.
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Materials and Methods
Protein expression. A synthetic gene corresponding to the REAMP sequence with a C-terminal V5 epitope 
was obtained from DNA2.0 (now ATUM, Inc.). The synthetic gene fragment was digested with the restriction 
enzymes NcoI and XhoI to allow cohesive end ligation into a modified version of the expression vector pET28c. 
This strategy placed the expression of REAMP under the T7 promoter, allowed selection by kanamycin and intro-
duced a His10 tag at the C-terminal. The C-terminal His-tag was replaced by a triple Strep-tag II sequence52 by 
cohesive end ligation of a synthetic DNA fragment after XhoI digestion. The same strategy was used to introduce 
the superfolder variant of GFP (sfGFP) at the C-terminal, with the codon for sfGFP L141 changed from CTC to 
CTG in order to remove an internal XhoI site. All constructs were confirmed by sequencing.
REAMP was expressed in E. coli strain BL21-AI (Invitrogen). Primary cultures of 100 ml were grown from 
a single bacterial colony overnight at 250 rpm, 37 °C in LB media. For protein purification, 10 ml of this pri-
mary culture was removed into each of three secondary 1 L cultures in 2.5 L baffled flasks. We found empirically 
that more mature cultures (A600 > 1) gave a higher final protein yield because of the overall greater cell mass. 
Induction was for two hours with 0.1 mM IPTG and 0.1% arabinose. Analytical cell lysates were prepared as 
required from small-scale cultures using the BugBuster reagent (Novagen).
Protein purification. The secondary cultures were harvested by centrifugation at 4000 × g for 15 min. 
The supernatant was discarded and the pellet resuspended in ~200 ml phosphate buffered saline (PBS). This 
suspension was briefly homogenized by hand before cell lysis in a continuous flow cell disruptor (Constant 
Systems Ltd) at 25 kpsi. The lysate was centrifuged at 10,000 × g for 10 min to remove unbroken cells and other 
debris. The cell membranes were then isolated from this clarified lysate by ultracentrifugation at 170,000 × g 
for 1 h. The supernatant was discarded, and the membrane pellet was resuspended in Buffer A (50 mM sodium 
phosphate buffer, pH 7.4, 150 mM NaCl, 5% glycerol). This membrane suspension was subject to at least 10 
passes in a hand-held homogenizer before being treated with a solubilizing detergent. This was one of either 
5-cyclohexylpentyl-β-D-maltoside (Cymal-5), nonyl-β-D-maltoside (NM), decyl-β-D-maltoside (DM) or 
dodecyl-β-D-maltoside (DDM) obtained from Anatrace at the highest purity and used at >10x critical micelle 
concentration. After incubation with gentle agitation for 1 h at room temperature, insoluble material was removed 
by ultracentrifugation as above in order to isolate soluble protein-detergent-lipid complexes (PDLCs).
For purification by immobilized metal affinity chromatography, a 1 ml Ni-NTA ‘HisTrap’ column (GE 
Healthcare) was equilibrated in Buffer B (Buffer A with the detergent of choice at ≥2x critical micelle concentra-
tion) plus 20 mM imidazole. Soluble PDLCs, also in 20 mM imidazole, were applied to the equilibrated column 
at a flow rate of 1 ml/min. The loaded column was then washed with 40 column volumes of Buffer B with 75 mM 
imidazole. Purified REAMP as a protein-detergent complex (PDC) was recovered by elution in Buffer B with 
0.5 M imidazole at a flow rate of 0.2 ml/min. Imidazole was immediately removed using a PD-10 desalting column 
(GE Healthcare) equilibrated in Buffer B. A centrifugal concentrator with either 30, 50 or 100 kDa molecular 
weight cut-off, depending on detergent, was used to bring purified REAMP to 2 mg/ml typically in 0.3–0.5 ml 
volume. Small aliquots (20 μl) were snap-frozen in liquid N2 and stored at −80 °C.
For purification using the triple Strep-tag II, membranes were solubilised in Buffer S (50 mM Tris, pH 8.0, 
150 mM NaCl, 5% Glycerol) plus 2.4% Cymal-5. After removing insoluble material by centrifugation as above, 
soluble protein was loaded onto a 1 ml Strep-tactin column (IBA) at a flow rate of 1 ml/min. After washing with 
20 column volumes of Buffer S plus 0.24% Cymal-5, REAMP-strep was eluted with 8 column volumes of Buffer S 
plus 0.24% Cymal-5 and 2.5 mM D-Desthiobiotin. The purified protein was concentrated with a 50 kDa MWCO 
cut-off centrifugal concentrator.
Protein characterization. The total protein concentration in cell and purification fractions was determined 
with a detergent-compatible Lowry assay (DC Protein Assay, BioRad). Co-purified phospholipid was determined 
with a commercial assay kit (Sigma-Aldrich). Amino acid analysis was performed by Alta Biosciences. The con-
centration of purified REAMP was determined from the absorbance at 280 nm using a calculated extinction 
coefficient of 5500/M/cm and a theoretical molecular weight of 13,757 Da (http://web.expasy.org/protparam/). 
For REAMP-Strep3 these values are 22,000/M/cm and 17, 830 Da, respectively.
SDS-PAGE analysis used commercial precast 10%, 12% or 4–20% acrylamide Tris-Glycine gels (NuSep or 
SERVA). Western blots were analysed with ImageJ53.
The following proteins were used as standards: Ferritin (molecular weight 440 kDa, Stokes radius 6.1 nm), 
Aldolase (158 kDa, 4.8 nm, sedimentation coefficient 7.3 S), conalbumin (75 kDa, 3.6 nm, 5.1 S), ovalbumin 
(44 kDa, 3.1 nm, 3.5 S). Size exclusion chromatography (SEC) was performed on an Äkta system using a Superdex 
S200 10/300 column (GE Healthcare). The void volume of this column was determined with Blue Dextran. For 
preparative size-exclusion of REAMP and mutants, the column was equilibrated with 1.5 column volumes of 
Buffer B before <1 ml of sample was injected at a flow rate of 0.5 ml/min. Size-exclusion data were analysed as 
described by Kunji et al.31.
Circular dichroism was performed on a Jasco J-1500 instrument at 0.2–0.5 mg/ml protein in a 0.1 cm path-
length cell. The purified protein was diluted into 5 mM sodium phosphate, pH 7.4, 135 mM NaF with 0.24% 
Cymal-5. Buffer backgrounds were collected and subtracted from each experiment. Wavelengths at which the 
high-tension (HT) voltage exceeded 700 V were excluded. Data were analysed with the SELCON3, CONTIN and 
K2D programs available at the Dichroweb server (http://dichroweb.cryst.bbk.ac.uk/html/home.shtml)54.
Protein sedimentation analysis was performed in a continuous 5–20% sucrose gradient with 0.24% Cymal-5 
to maintain protein solubility. An 80 μl sample consisting of REAMP at 1.4 mg/ml and the calibration stand-
ards Aldolase, Conalbumin and Ovalbumin at 1 mg/ml was loaded onto a 2 ml gradient and ultracentrifuged 
in a Beckman TLS-55 swing-out rotor for 6 h at 118,000 × g. Molecular weight (M) in kDa was determined as 
described by Erickson30 using Eq. 1:
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where S is sedimentation coefficient (Svedberg units) obtained from sucrose gradient sedimentation and Rs is 
Stokes’ radius (nm) from size-exclusion and solution dynamic light scattering.
15N-labelled samples of REAMP were prepared from cells grown in supplemented minimal media as 
described55. Purified protein was concentrated to 5 mg/ml in Buffer A plus 0.24% Cymal-5 and 10% D2O, before 
being transferred to 1.7 mm NMR tubes. All NMR experiments were performed on a Brucker Avance III HD 
700 MHz NMR instrument equipped with a 1.7 mm TCI microcryoprobe at 40 °C. Excitation sculpting 1D 1H 
spectra with water suppression (zgesgp) were acquired using 1024 scans per experiment, an interscan delay of 1 s 
and a spectral width of 14 ppm with 32 K complex points to check the quality of samples. 1H-15N BEST-TROSY 
spectra (b_trosyf3gpph.2) were acquired with a spectral width of 14 ppm in 1H and 33 ppm in 15N with a relax-
ation delay of 0.2 s. The spectra were processed using NMRPipe56 and analysed using CcpNmr Analysis version 
2.4.157.
Mass spectrometry was carried out essentially as described32 in 0.2 M ammonium acetate, 0.24% Cymal-5.
Molecular Dynamics. A molecular model of REAMP was made as follows. Four α-helices were built and 
positioned with Chimera, decorated and packed using SCWRL4, and the loops built with Modeller58,59. Hydrogen 
atoms were added consistent with pH 7 and the model was embedded in a POPC lipid bilayer in a box of SPC 
waters containing 0.15 M NaCl. The system was parameterized with the OPLS/AA and Berger-lipid forcefields 
and energy minimized for 5000 steps prior to molecular dynamics simulations. Simulations were performed for 
200 ns at 310 K using periodic boundary conditions and PME long-range electrostatics with GROMACS-4.6.7. 
Presentation figures were prepared with PyMol.
Heme binding. Heme binding assays were carried out in Buffer A. Hemin was freshly diluted to 150 μM and 
introduced in small aliquots to 1 ml of 1.4 μM protein in a 1 cm pathlength cuvette. Cymal-5 was maintained at 
0.012% and data were collected after a 10 s equilibration. Kinetic data were recorded in identical buffers using a 
stopped-flow instrument (Applied Photophysics) in absorbance mode.
For redox potentiometry, the protein was diluted to 50 μM in Buffer A plus 0.012% Cymal-5 before Hemin was 
added to a 2-fold excess. Potentiometry was performed as described60 and the data were fit to the Nernst equation 
for a one-electron reduction (Eq. 2):
‐Absorbance Abs (Abs /(10 ) 1) (2)min max E E /59m h= + +
where Absmin and Absmax are the minimum and maximum observed absorbance signals respectively, Em is the 
midpoint potential and Eh is the ambient redox potential with respect to the standard hydrogen electrode. 
Incubation times of 30 min were required to reach equilibrium at each voltage, and over longer timescales this 
led to hysteresis in the reverse (oxidizing) sweep of REAMPS35H/L94H. This may arise from oxidative damage to the 
detergent micelle which destabilizes the membrane protein.
Electron transfer assays were performed in Buffer A plus 0.012% Cymal-5 at 1.4 μM protein, 1 μM hemin, 
0.0025% H2O2, 1 mM ABTS at 25 °C. The extinction coefficient of ABTS at 420 nm was taken as 36,000 /M /cm.
Data Availability Statement
All of the raw data underpinning this work is available from the authors on request.
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